Papua New Guinea vs San Marino: Protecting minority investors: Ease of shareholder suits index (0-10)
Papua New Guinea
80
in 2013
San Marino
80
in 2013
Papua New Guinea rank
12th
San Marino rank
12th
Protecting minority investors: Ease of shareholder suits index (0-10) over time
- Papua New Guinea
- San Marino
How they compare
Papua New Guinea currently reports 80 against 80 in San Marino, a difference of 0.
Across all 9 years both countries report, San Marino has been ahead every year.
Papua New Guinea ranks 12th and San Marino ranks 12th of 191 countries.
Head to head by decade
| Decade | Papua New Guinea | San Marino | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 80 | 80 | 0 | — |
| 2010s | 80 | 80 | 0 | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher protecting minority investors: ease of shareholder suits index (0-10), Papua New Guinea or San Marino?
- Papua New Guinea, at 80 against 80 in San Marino as of 2013.
- What is the difference in protecting minority investors: ease of shareholder suits index (0-10) between Papua New Guinea and San Marino?
- 0, with Papua New Guinea ahead.
- How many years of comparable data are there for Papua New Guinea and San Marino?
- 9 years are reported by both, from 2005 to 2013.
- How do Papua New Guinea and San Marino rank globally for protecting minority investors: ease of shareholder suits index (0-10)?
- Papua New Guinea ranks 12th and San Marino ranks 12th of 191 countries.
- Where does this data come from?
- The World Bank, published as Protecting minority investors: Ease of shareholder suits index (0-10) (DB06-14 methodology) - Score. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The score for ease of shareholder suits index benchmarks economies with respect to the regulatory best practice on the indicator. The score is indicated on a scale from 0 to 100, where 0 represents the worst regulatory performance and 100 the best regulatory performance, and is computed based on the methodology in the DB06-14 studies.